trending Market Intelligence /marketintelligence/en/news-insights/trending/8Jz1TFMcQc0hsuXONdBrQQ2 content esgSubNav
In This List

Aclaris Therapeutics adds director

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Aclaris Therapeutics adds director

Aclaris Therapeutics Inc. added Andrew Schiff to its board.

Schiff is a managing partner at Aisling Capital LLC.